Related Experiment Videos
[An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
Li-Fei Wang1, Jing-Xue Ma, Jian-Zong Liu
1The Second Hispital, Hebei Medical University, Shijiazhuang 050000, China. wlfhb@gzsums.edu.cn
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|September 30, 2004
Summary
The combination of Hyaluronidase (20 IU) and Plasmin (1 IU) safely induces complete posterior vitreous detachment (PVD) in animal models. This intravitreal injection approach shows no retinal toxicity, offering a promising method for PVD induction.
Area of Science:
- Ophthalmology
- Retinal Science
- Pharmacology
Context:
- Posterior vitreous detachment (PVD) is a common age-related condition.
- Current methods for PVD induction require further investigation for safety and efficacy.
- Intravitreal injections are a common route for ocular drug delivery.
Purpose:
- To determine the safe dosage of intravitreal Hyaluronidase and Plasmin for PVD induction.
- To evaluate the efficacy of Hyaluronidase and Plasmin, alone and in combination, in creating PVD.
- To assess the safety profile, including retinal toxicity and inflammatory response, of these agents.
Summary:
- Animal studies evaluated intravitreal injections of varying doses of Hyaluronidase and Plasmin.
- Combinations of Hyaluronidase (20 IU) and Plasmin (1 IU) demonstrated efficacy in inducing complete PVD without adverse effects.
- Higher doses of Hyaluronidase and Plasmin resulted in inflammatory responses and retinal changes.
Impact:
- Establishes safe and effective intravitreal dosages for Hyaluronidase and Plasmin in PVD induction.
- Provides a foundation for potential therapeutic applications of PVD induction.
- Highlights the importance of precise dosing to avoid ocular toxicity.